New Phase 2 Trial Boosts Stage III NSCLC Treatment
In a groundbreaking effort to enhance the treatment landscape of stage III non-small cell lung cancer (NSCLC), researchers have recently ...
In a groundbreaking effort to enhance the treatment landscape of stage III non-small cell lung cancer (NSCLC), researchers have recently ...
In the realm of oncology, the development of effective treatments for cancer has long been a significant challenge. Among various ...
In recent years, immunotherapy has emerged as a front-line treatment paradigm for various types of cancers, including esophageal squamous cell ...
Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the most transformative advances in cancer immunotherapy over ...
In a groundbreaking retrospective study published in BMC Cancer, researchers have unveiled compelling evidence that low-dose radiotherapy (LDRT) combined with ...
In a groundbreaking advancement for hematologic oncology, researchers from the Alliance for Clinical Trials in Oncology have reported unprecedented remission ...
Researchers from the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), affiliated with the University of Maryland ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine